Good morning, everyone, and nice to see you again. A bumpy ride today as we labored to hustle the short people off to the school house. Nonetheless, we survived and this calls, of course, for a cup or two of much-needed stimulation. Please join us. Meanwhile, here are a few tidbits we came across. If you have a chance, let us know about anything else that appears interesting. Have a great day...
Novartis Blood Cancer Drug Meets Study Goal (Reuters)
Whistleblowers And Smear Lawsuits (Nature News)
Daiichi Has Still Not Gained From Buying Ranbaxy (Wall Street Journal)
US Drug Prices Outpaced Other Medical Costs: GAO (Reuters)
A Link Between Sunlight And Drug Efficacy Is Found (InPharma Technologist)
Australia Blocks Subsidies For New Drugs (Pharma Times)
Labopharm CEO Steps Down Amid Review (Canadian Business)